Back to mobile site

More on ZYME

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+1,007.7% Growth)
- Ratings (9.5 Score)
- Holders

Upcoming Events

- Earnings (11/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Zymeworks (NQ:ZYME)
Delayed: 28.03 +1.12 (4.16%)
Prev. Close $26.91  
Open$26.96 
52 Wk High$ 
52 Wk Low$ 
Day High$28.03 
Day Low$26.90 
P/E N/A  
EPS$ 
Volume360,689 

Friends, Peers and Foes (?): TBPH, RPRX, GLMD, RPTX, INM (more...)

Oct 19, 2026 06:00 AM Zymeworks names Suzanne Monahan as SVP Commercial for YUPELRI
Oct 19, 2026 06:00 AM Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma
Oct 16, 2026 04:16 PM Form PRE 14A Zymeworks Inc. For: Dec 15
Oct 15, 2026 06:00 AM Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results
Oct 9, 2026 06:28 PM Form 4 Zymeworks Inc. For: Oct 09 Filed by: Schayowitz Adam
Oct 9, 2026 11:17 AM Form 144 Zymeworks Inc. Filed by: Schayowitz Adam
Oct 7, 2026 07:14 AM Zymeworks (ZYME) PT Raised to $34 at Truist Securities
Sep 29, 2026 09:34 AM TD Cowen Reinstates Zymeworks (ZYME) at Buy
Sep 29, 2026 05:28 AM Zymeworks (ZYME) Reiterated at Market Outperform by Citizens as Theravance Biopharma Acquisition Closed
Sep 28, 2026 06:01 AM Zymeworks raises 2026 guidance after closing Theravance acquisition
View All Articles

Entities mentioned with ZYME

View All Entities